Beta Lactamase Producing Escherichia coli, Klebsiella pneumoniae and Methicillin Resistant Staphylococcus aureus among Uropathogens

Vivek Kumar Singh, R. Tuladhar, M. Chaudhary
{"title":"Beta Lactamase Producing Escherichia coli, Klebsiella pneumoniae and Methicillin Resistant Staphylococcus aureus among Uropathogens","authors":"Vivek Kumar Singh, R. Tuladhar, M. Chaudhary","doi":"10.3126/NJST.V16I1.14364","DOIUrl":null,"url":null,"abstract":"Urinary tract infection (UTI) is the leading cause of morbidity and health care expenditures in persons of all the ages. The impact of disease is high in the low-resource developing countries due to lack of awareness about the UTIs caused by extended spectrum beta lactamase producing pathogens and methicillin resistant Staphylococcus aureus . This study represents a cross-sectional analysis of UTI prevalence in patients attending at KIST Medical College Teaching Hospital, Imadole, Lalitpur. Bacterial isolates were identified using standard biochemical tests. The antimicrobial susceptibility to various drugs and confirmation of the extended spectrum s-lactamase (ESBL) and methicillin resistant Staphylococcus aureus (MRSA) production was done following Clinical & Laboratory Standards Institute (CLSI) guidelines. During the study period, 303 (24.08% of urine submissions) UTIs were confirmed. Among these 303 strains, E. coli was the most common, representing 65.34% of the isolates, followed by S. aureus (6.93%) and other pathogens (27.72%). Prevalence of ESBL E. coli, K. pneumoniae and MRSA in the urinary isolates were found to be 38.38 %, 35 % and 47.61 % respectively. Empiric treatment for UTIs in Nepal should be reconsidered and prudent use of antibiotics, particularly Gentamycin, is highly recommended. The recent spread of ESBL-producing Enterobacteriaceae and MRSA is striking and underlines the need for further studies. Nepal Journal of Science and Technology Vol. 16, No.1 (2015) pp. 105-112","PeriodicalId":129302,"journal":{"name":"Nepal Journal of Science and Technology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepal Journal of Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/NJST.V16I1.14364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Urinary tract infection (UTI) is the leading cause of morbidity and health care expenditures in persons of all the ages. The impact of disease is high in the low-resource developing countries due to lack of awareness about the UTIs caused by extended spectrum beta lactamase producing pathogens and methicillin resistant Staphylococcus aureus . This study represents a cross-sectional analysis of UTI prevalence in patients attending at KIST Medical College Teaching Hospital, Imadole, Lalitpur. Bacterial isolates were identified using standard biochemical tests. The antimicrobial susceptibility to various drugs and confirmation of the extended spectrum s-lactamase (ESBL) and methicillin resistant Staphylococcus aureus (MRSA) production was done following Clinical & Laboratory Standards Institute (CLSI) guidelines. During the study period, 303 (24.08% of urine submissions) UTIs were confirmed. Among these 303 strains, E. coli was the most common, representing 65.34% of the isolates, followed by S. aureus (6.93%) and other pathogens (27.72%). Prevalence of ESBL E. coli, K. pneumoniae and MRSA in the urinary isolates were found to be 38.38 %, 35 % and 47.61 % respectively. Empiric treatment for UTIs in Nepal should be reconsidered and prudent use of antibiotics, particularly Gentamycin, is highly recommended. The recent spread of ESBL-producing Enterobacteriaceae and MRSA is striking and underlines the need for further studies. Nepal Journal of Science and Technology Vol. 16, No.1 (2015) pp. 105-112
尿路病原体中产生β -内酰胺酶的大肠杆菌、肺炎克雷伯菌和耐甲氧西林金黄色葡萄球菌
尿路感染(UTI)是所有年龄段人群发病率和卫生保健支出的主要原因。在资源匮乏的发展中国家,由于缺乏对广谱β -内酰胺酶产生病原体和耐甲氧西林金黄色葡萄球菌引起的尿路感染的认识,疾病的影响很大。本研究对在拉利特普尔Imadole KIST医学院教学医院就诊的患者进行了尿路感染患病率的横断面分析。采用标准生化试验鉴定分离细菌。根据临床与实验室标准协会(CLSI)的指导方针,对各种药物的抗菌敏感性和扩展谱s-内酰胺酶(ESBL)和耐甲氧西林金黄色葡萄球菌(MRSA)的生产进行了确认。在研究期间,确认有303例(24.08%)尿路感染。303株病原菌中以大肠杆菌最多,占65.34%,其次为金黄色葡萄球菌(6.93%),其他病原菌占27.72%。尿分离株中ESBL大肠杆菌、肺炎克雷伯菌和MRSA的感染率分别为38.38%、35%和47.61%。应重新考虑尼泊尔对尿路感染的经验性治疗,并强烈建议谨慎使用抗生素,特别是庆大霉素。最近产生esbl的肠杆菌科和MRSA的传播是惊人的,强调了进一步研究的必要性。尼泊尔科学技术杂志,第16卷第1期(2015),pp. 105-112
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信